SAM
ABBV icon

Secure Asset Management’s AbbVie ABBV Stock Holding History

Secure Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Sell
5,460
-490
-8% -$105K 0.19% 116
2026
Q1 		$1.29M Buy
5,950
+490
+9% +$109K 0.2% 112
2025
Q4 		$1.25M Sell
5,460
-272
-5% -$62K 0.2% 116
2025
Q3 		$1.4M Sell
5,732
-793
-12% -$161K 0.23% 108
2025
Q2 		$1.21M Buy
6,525
+798
+14% +$148K 0.22% 112
2025
Q1 		$1.2M Sell
5,727
-6,814
-54% -$1.32M 0.24% 109
2024
Q4 		$2.23M Buy
12,541
+1,337
+12% +$246K 0.34% 69
2024
Q3 		$2.21M Buy
11,204
+1,513
+16% +$282K 0.37% 55
2024
Q2 		$1.66M Sell
9,691
-2,330
-19% -$386K 0.31% 73
2024
Q1 		$2.19M Sell
12,021
-911
-7% -$157K 0.51% 39
2023
Q4 		$2M Sell
12,932
-2,868
-18% -$418K 0.54% 43
2023
Q3 		$2.36M Sell
15,800
-2,166
-12% -$318K 0.7% 30
2023
Q2 		$2.42M Buy
17,966
+274
+2% +$40.2K 0.74% 28
2023
Q1 		$2.82M Sell
17,692
-230
-1% -$35.2K 0.94% 20
2022
Q4 		$2.9M Sell
17,922
-1,306
-7% -$200K 1.04% 17
2022
Q3 		$2.58M Sell
19,228
-27
-0.1% -$3.87K 1.45% 11
2022
Q2 		$2.95M Buy
19,255
+22
+0.1% +$3.36K 1.63% 12
2022
Q1 		$3.12M Sell
19,233
-260
-1% -$37.8K 1.41% 12
2021
Q4 		$2.64M Sell
19,493
-37
-0.2% -$4.37K 1.07% 13
2021
Q3 		$2.11M Buy
19,530
+793
+4% +$90.6K 1.04% 18
2021
Q2 		$2.11M Buy
18,737
+1,419
+8% +$160K 1.07% 16
2021
Q1 		$1.87M Sell
17,318
-3,979
-19% -$426K 1.04% 18
2020
Q4 		$2.28M Buy
21,297
+434
+2% +$41.7K 1.34% 16
2020
Q3 		$1.83M Sell
20,863
-1,589
-7% -$150K 1.25% 17
2020
Q2 		$2.2M Buy
22,452
+3,446
+18% +$303K 1.55% 13
2020
Q1 		$1.45M Sell
19,006
-3,566
-16% -$304K 1.56% 16
2019
Q4 		$2M Buy
+22,572
New +$1.87M 1.41% 18

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Secure Asset Management's ABBV Position: Q2 2026 in Review

Secure Asset Management reduced its AbbVie (ABBV) stake by 8.2% in Q2 2026, selling an estimated $105K and leaving 5,460 shares worth $1.37M. The position accounts for 0.19% of the portfolio, ranked #116.

Secure Asset Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.12M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Secure Asset Management held 5,460 shares of AbbVie worth $1.37M as of Q2 2026.
  • Secure Asset Management sold 490 AbbVie shares in Q2 2026, an estimated $105K.
  • AbbVie made up 0.19% of Secure Asset Management's portfolio in Q2 2026, its #116 holding.
  • Secure Asset Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Secure Asset Management's AbbVie position peaked at $3.12M in Q1 2022.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Secure Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.